Epilogue, which sells the popular GB Operator, is planning to ship its $60 SN Operator starting in April of next year. The ...
Testing wireless devices requires that you either just put them into live situations and hope for the best or emulate their conditions and analyze their actions. octoPal from octoScope lets you ...
Developers, makers and electronic enthusiasts they would like to be able to easily access or emulate devices using a wide variety of protocols, may be interested in the Protocol Droid created by ...
Quantum neuroelectronic devices emulate brain synapses, show potential to mitigate cognitive decline
(Nanowerk Spotlight) The complex neural networks of the human brain, with their trillions of interconnected neurons communicating via synapses, endow us with unparalleled cognitive abilities. Yet the ...
The M4 Mac Mini, the latest addition to Apple’s lineup, is turning heads in the tech community for its impressive capabilities as an emulation device. While the Mac Mini has long been a favorite for ...
Medical device maker Emulate Therapeutics (EMTX) has set terms for a proposed IPO that would raise around $13M. Emulate said in a filing that it is looking to offer 2.5M shares priced between $4 and ...
How-To Geek on MSN
Dolphin Emulator now has better frame latency, RetroAchievements on Android, and more
Dolphin Progress Report, Release 2512, comes with substantial updates that focus on lowering frame latency. This improves performance in troublesome games and finally brings RetroAchievements support ...
From its introduction in 1995, the Universal Serial Bus (USB) quickly gained widespread acceptance for connecting peripherals to personal computers. More recently, its ease of use, expandability, high ...
EMulate Therapeutics, Inc. has filed proposed terms for a $12.5 million IPO. The firm is developing medical device technology treatment options for various serious medical conditions. EMulate ...
EMulate Therapeutics, Inc. (EMTx) announces the acceptance of a publication of its pre-clinical animal model, testing the effect of its ulRFE® paclitaxel (A1A) signal against a DIPG tumor cell line.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results